Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-12
DOI
10.1038/s41598-017-03864-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting the metabolism and physiological functions of caprylic acid (C8:0) with special focus on ghrelin octanoylation
- (2016) Fanny Lemarié et al. BIOCHIMIE
- Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study
- (2016) Einav Ratzon et al. BMC CANCER
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte–neuron lactate and ketone body shuttle systems
- (2016) Jonathan Thevenet et al. FASEB JOURNAL
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Determination of DNA Hypermethylation Using Anti-cancer Drug-Temozolomide
- (2015) Seda Nur Topkaya et al. ELECTROANALYSIS
- Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs
- (2015) Mauro Ravera et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway
- (2014) Iva Jelínková et al. BIOCHEMICAL PHARMACOLOGY
- Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
- (2014) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation
- (2014) Youngmi Cho et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application
- (2014) Sarah Theiner et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be?
- (2014) Ilaria Zanellato et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
- (2014) Yao-Rong Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synthetic Methods for the Preparation of Platinum Anticancer Complexes
- (2013) Justin J. Wilson et al. CHEMICAL REVIEWS
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- DNA methylation inhibitors in cancer: Recent and future approaches
- (2012) Christina Gros et al. BIOCHIMIE
- Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models
- (2012) Jenny Z. Zhang et al. Metallomics
- Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
- (2012) Xue Xue et al. MOLECULAR PHARMACEUTICS
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
- (2011) Sabine Hagemann et al. PLoS One
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Targeting DNA methylation for epigenetic therapy
- (2010) Xiaojing Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The effect of oral lipids and circulating lipoproteins on the metabolism of drugs
- (2009) Jigar P Patel et al. Expert Opinion on Drug Metabolism & Toxicology
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- The role of DNA hypermethylation and demethylation in cancer and cancer therapy
- (2008) Moshe Szyf Current Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started